Syllabus · Current · V5 (2025) · Haematological and Immunological System

N3 · Haematological Measurement

N3.i · Coagulation & Viscoelastic Testing

Official V5 objective
Describe the methods for assessing coagulation, including viscoelastic assays.
2 SAQ topics 3 SAQ appearances 4 VIVA stations

Written examination

SAQ history

3 appearances
Coagulation Tests
2 exam appearances
Outline how the following tests assess coagulation: a. Prothombin Time (PT) b. Activated Partial Thromboplastin Time (APTT) c. Activated Clotting Time (ACT) d. Thromboelastography (TEG or ROTEM)
61%
Outline how the following tests assess coagulation: a) Prothrombin Time (PT); b) Activated Partial Thromboplastin Time (APTT); c) Activated Clotting Time (ACT); d) Thromboelastogram (TEG or ROTEM)
0%
With respect to viscoelastic assays, describe the expected alterations and the underlying mechanisms resulting from the following: a) platelet dysfunction (40% of marks), b) therapeutic heparin use (40% of marks), c) hyperfibrinolysis (20% of marks). Either TEG or ROTEM is acceptable for your answer.
29%

Oral examination

VIVA history

4 stations

Sources: objective text from the relevant CICM syllabus; historical SAQ and VIVA wording from CICM examiner reports.